The Use of Ascorbigen in the Treatment of Fibromyalgia Patients: A Preliminary Trial
| Title: | The Use of Ascorbigen in the Treatment of Fibromyalgia Patients: A Preliminary Trial |
|---|---|
| Authors: | Ben Bramwell; Scott Ferguson; Nancy Scarlett Nd Anna Macintosh |
| Contributors: | The Pennsylvania State University CiteSeerX Archives |
| Source: | http://www.thorne.com/altmedrev/.fulltext/5/5/455.pdf. |
| Collection: | CiteSeerX |
| Description: | Fibromyalgia is a perplexing and widespread syndrome, afflicting about two percent of the U.S population: 3.4 percent of women and 0.5 percent of men.1 A rather complex picture of the syndrome has arisen, with patients manifesting a variety of abnormalities, including: in-creased homocysteine in the cerebrospinal fluid,2 alterations in several chemical pain mediators |
| Document Type: | text |
| File Description: | application/pdf |
| Language: | English |
| Relation: | http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.576.4006; http://www.thorne.com/altmedrev/.fulltext/5/5/455.pdf |
| Availability: | http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.576.4006; http://www.thorne.com/altmedrev/.fulltext/5/5/455.pdf |
| Rights: | Metadata may be used without restrictions as long as the oai identifier remains attached to it. |
| Accession Number: | edsbas.925B0973 |
| Database: | BASE |